Plasma levels of SPRY4-IT1 were increased in 70 melanoma patients compared with 79 healthy controls.[91] In addition, multivariate survival analysis revealed that a high SPRY4-IT1 expression level in plasma is an independent negative prognostic factor for overall survival in melanoma patients. The gene discussed is SPRY4; the disease is melanoma.